Clinical trials sponsored by Blokhin's Russian Cancer Research Center

Phase breakdown

Conditions studied

Recruiting trials led by Blokhin's Russian Cancer Research Center

• A Study of Dabrafenib Plus Cetuximab/Panitumumab With FOLFOX in the First Line of Therapy in People With Metastatic Colorectal Cancer
  NCT06978400 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Comparison of Molecular-Genetic Concordance of the Primary Tumor and Brain Metastases of Colorectal Cancer
  NCT06449989 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Prophylactic Mesh Placement During Stoma Closure After Low Anterior Resection
  NCT05939687 · Phase: Phase 3 · Ages: 18 Years to 85 Years · Sex: All (male and female) · 1 location

Common questions

How many trials is Blokhin's Russian Cancer Research Center recruiting for?

Blokhin's Russian Cancer Research Center is the lead sponsor of 3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.